Sheppard Mullin Represents Provepharm Life Solutions in Acquisition of Apollo Pharmaceuticals USA
Sheppard Mullin represented French-based pharmaceutical company, Provepharm Life Solutions, in its acquisition of Florida-based Apollo Pharmaceuticals USA Inc., which specializes in the commercialization of sterile injectable products for hospital use. Provepharm's strategic purchase enables it to strengthen its position in the US market, particularly through the expansion of its product range, initially by integrating Apollo’s four registered products.
The Sheppard Mullin deal team was led by partner Luca Salvi and included special counsel Cedric Powell and Malika Levarlet and associate Karl Buhler. Other members of the team included, among others, Allison Fulton on FDA matters; Keith Gercken and John Crisp on tax matters; Claudia Hinsch on employee benefits matters; Sean Kirby on labor matters; and Carlo Van den Bosch on IP matters.
Click here to read the press release.